David Laha, DPM
Podiatrist · Overland Park, KSNPI 1992783450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $347 and has fallen 55.2% since, to $156 in 2025.
Across 59 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$229
- Kowa Pharmaceuticals America, Inc.$103
- Paratek Pharmaceuticals, Inc.$100
- Nevro Corp.$95
- Organogenesis Inc.$92
- AbbVie$77
- plus $448 from 16 others
What the payments were for
- Food & beverage$1,144100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $229 |
| Kowa Pharmaceuticals America, Inc. | 7 | $103 |
| Paratek Pharmaceuticals, Inc. | 6 | $100 |
| Nevro Corp. | 4 | $95 |
| Organogenesis Inc. | 4 | $92 |
| AbbVie | 3 | $77 |
| Acumed LLC | 1 | $50 |
| Convatec Inc. | 2 | $44 |
| In2bones USA, LLC | 1 | $39 |
| Boston Scientific | 2 | $37 |
| Nabriva Therapeutics, PLC | 2 | $34 |
| Johnson & Johnson | 2 | $33 |
| Integra Lifesciences Corporation | 2 | $30 |
| Smith+Nephew | 2 | $29 |
| Kerecis Limited | 1 | $28 |
| Surgenex LLC | 1 | $22 |
| Biotissue Holdings Inc. | 1 | $20 |
| Titan Surgical Group, LLC | 1 | $19 |
| Abbott | 1 | $19 |
| Zimmer Biomet | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Amgen | 1 | $13 |
How this compares
$1,144 in reported general payments places this provider in the 55th percentile of 30 podiatrist providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 29 | $506 |
| Meloxicam | 250 | $436 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $352 |
| Cephalexin | 17 | $80 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Overland Park
- Jeffrey RoithOverland Park$69K
- Matthew GallianoOverland Park$19K
- Jennifer PhillipsOverland Park$3K
- David BlanchoGalena$193K
- Thomas TruongWichita$11K
- Nhi leLenexa$3K
- Henry GoppertTopeka$3K
- Nicholas PosgeEl Dorado$3K
- Kirsten PaulsrudHutchinson$2K
- Frank GalbraithWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.